02/12/2022

EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
25/11/2022

The time to act is now! Biotechnology for global transformation

23/11/2022

Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022

EuropaBio hosted its inaugural Healthcare BioForum on October 5, 2022. The roundtable brought together representatives from SMEs, large companies, DGs GROW, Santé and RTD, European Parliament and Member States to discuss links between innovation, investment, and excellence in European healthcare biotechnology.
16/11/2022

Policy Proposal for New Genomic Techniques – Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
14/11/2022

A new initiative for building a more competitive Europe: EuropaBio announces Biomanufacturing Platform

Possible solutions to improve the European regulatory procedures for clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
28/10/2022

Europe’s potential in advanced Biomanufacturing at the centre of EFIB 2022 discussions

11/10/2022

Factsheet – Vision for Europe: Excellence

11/10/2022

Factsheet – Vision for Europe: Investment

11/10/2022

Factsheet – Vision for Europe: Innovation

03/10/2022

Vision for Europe: Innovation, Investment, Excellence | Claire Skentelbery, EuropaBio

25/09/2022

European Biotech Week 2022 starts today!

21/09/2022

Vision for Europe:Innovation, Investment, Excellence | Yordan Aleksandrov, Pfizer

21/09/2022

Vision for Europe: Innovation, Investment, Excellence | Tineke Van hooland, bio.be/essenscia

21/09/2022

Vision for Europe: Innovation, Investment, Excellence | Thomas Bols, PTC Therapeutics

21/09/2022

Factsheet – Sustainable Investment and the EU Bioeconomy

19/09/2022

Biotech SMEs are the heart of Europe’s healthcare ecosystem – hear their voice.

07/09/2022

EuropaBio response to the public consultation on the proposal for a Regulation on substances of human origin (SoHO)

07/09/2022

Factsheet – Increased regulatory efficiency; what we need for the next generation of medicine

07/09/2022

Factsheet – European Health Data Space

07/09/2022

Factsheet – A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare